---
title: "Psoriasis"
canonical: "https://www.pharmalegacy.com/indications/inflammation-immunity-autoimmunity/psoriasis/"
lastmod: "2024-11-18T11:51:18+00:00"
generator: "llm-mirrors/1.0.19"
---

Psoriasis causes red, crusty, flaky, crusty patches of skin that are usually covered with silvery scales. It affects roughly 2-3% of the worldwide population, equally among men and women. To this day, it has no known cure, but only a range of treatments that alleviate its symptoms. Psoriasis is a multifactorial condition, with one of its contributing factors being autoimmune diseases (Celiac disease, Crohn’s disease, rheumatoid arthritis); Some experts even believe that Psoriasis is an autoimmune disease itself.
With T-cells carrying out a ruthless onslaught on skin cells in psoriasis, the search for better drugs to treat the condition has to be equally ruthless, and unrelenting. This is exactly what we can promise you at PharmaLegacy. An Unrelenting team of scientists with 15 years of experience in pharmacology. State-of-the-art IL-23 induced hyperplasia in mice and Imiquimod-induced psoriasis in mice and rats models.
Put your trust in the right CRO. Put your trust in PharmaLegacy.